반응식
[O-:1][C:2]1[CH:11]=[C:10]2[C:5]([CH:6]=[CH:7][C:8]([S:12]([O-:15])(=[O:14])=[O:13])=[CH:9]2)=[CH:4][CH:3]=1.[Na+].[Na+].Cl[CH2:19][CH2:20][CH2:21][C:22]1[CH:27]=[CH:26][N:25]=[CH:24][CH:23]=1>>[N:25]1[CH:26]=[CH:27][C:22]([CH2:21][CH2:20][CH2:19][O:1][C:2]2[CH:11]=[C:10]3[C:5]([CH:6]=[CH:7][C:8]([S:12]([OH:15])(=[O:13])=[O:14])=[CH:9]3)=[CH:4][CH:3]=2)=[CH:23][CH:24]=1참가 물질
3
실험 절차
Following a procedure analogous to that for the synthesis of Intermediate 26B, sodium 7-oxidonaphthalene-2-sulfonate (Pfaltz and Bauer, 200 mg, 0.75 mmol) and 4-(3-chloropropyl)pyridine (116 mg, 0.75 mmol) were converted to the title compound (109 mg, 43%). 1H NMR (DMSO-d6) δ 8.65, (s, 1H), 8.58 (s, 1H), 8.12 (s, 1H), 7.92 (d, J=8.4 Hz, 1H), 7.79 (d, J=8.7 Hz, 1H), 7.62 (d, J=5.7 Hz, 1H), 7.57 (dd, J=8.5, 1.9 Hz, 2H), 7.44 (s, 1H), 7.27 (d, J=8.7, 1H), 4.20 (t, J=6.5 Hz, 2H), 3.10 (t, J=7.7 Hz, 2H), 2.30-2.21 (m, 2H); MS(ESI+) m/z 344.1 (M+H)+.
출처 및 근거
- ORD 기록
- ord-c43cf8f643424ce68d696d6b866efb94
- 출처 데이터셋
- uspto-grants-2016_05
- 특허 번호
- US09346795B2
연결된 노트
불러오는 중…